Index by Author

January 1999; 48 (1)
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

A

  1. Agius, L

    • Leptin enhances glycogen storage in hepatocytes by inhibition of phosphorylase and exerts an additive effect with insulin. Diabetes January 1999 48:15-20; doi:10.2337/diabetes.48.1.15

  2. Ahrén, B

    • Hormone-sensitive lipase, the rate-limiting enzyme in triglyceride hydrolysis, is expressed and active in beta-cells. Diabetes January 1999 48:228-232; doi:10.2337/diabetes.48.1.228

  3. Aiston, S

    • Leptin enhances glycogen storage in hepatocytes by inhibition of phosphorylase and exerts an additive effect with insulin. Diabetes January 1999 48:15-20; doi:10.2337/diabetes.48.1.15

  4. Alm, P

    • Heme oxygenase and carbon monoxide: regulatory roles in islet hormone release: a biochemical, immunohistochemical, and confocal microscopic study. Diabetes January 1999 48:66-76; doi:10.2337/diabetes.48.1.66

  5. Anai, M

    • Enhanced insulin-stimulated activation of phosphatidylinositol 3-kinase in the liver of high-fat-fed rats. Diabetes January 1999 48:158-169; doi:10.2337/diabetes.48.1.158

  6. Arner, P

    • Polymorphism of the human beta3-adrenoceptor gene forms a well-conserved haplotype that is associated with moderate obesity and altered receptor function. Diabetes January 1999 48:203-205; doi:10.2337/diabetes.48.1.203

  7. Asano, T

    • Enhanced insulin-stimulated activation of phosphatidylinositol 3-kinase in the liver of high-fat-fed rats. Diabetes January 1999 48:158-169; doi:10.2337/diabetes.48.1.158

  8. Avogaro, A

    • Restoration of early rise in plasma insulin levels improves the glucose tolerance of type 2 diabetic patients. Diabetes January 1999 48:99-105; doi:10.2337/diabetes.48.1.99

B

  1. Badenhoop, K

    • IDDM patients neither show humoral reactivities against endogenous retroviral envelope protein nor do they differ in retroviral mRNA expression from healthy relatives or normal individuals. Diabetes January 1999 48:215-218; doi:10.2337/diabetes.48.1.215

  2. Barucci, N

    • Differential effects of safflower oil versus fish oil feeding on insulin-stimulated glycogen synthesis, glycolysis, and pyruvate dehydrogenase flux in skeletal muscle: a 13C nuclear magnetic resonance study. Diabetes January 1999 48:134-140; doi:10.2337/diabetes.48.1.134

  3. Barzilai, N

    • Surgical removal of visceral fat reverses hepatic insulin resistance. Diabetes January 1999 48:94-98; doi:10.2337/diabetes.48.1.94

  4. Baur, L A

    • Relationships between maternal risk of insulin resistance and the child's muscle membrane fatty acid composition. Diabetes January 1999 48:112-116; doi:10.2337/diabetes.48.1.112

  5. Baynes, J W

    • Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes January 1999 48:1-9; doi:10.2337/diabetes.48.1.1

  6. Beisswenger, P J

    • Metformin reduces systemic methylglyoxal levels in type 2 diabetes. Diabetes January 1999 48:198-202; doi:10.2337/diabetes.48.1.198

  7. Berger, D

    • No evidence for association between IDDMK(1,2)22, a novel isolated retrovirus, and IDDM. Diabetes January 1999 48:209-214; doi:10.2337/diabetes.48.1.209

  8. Bieg, S

    • Recombinant human platelet-activating factor acetylhydrolase reduces the frequency of diabetes in the diabetes-prone BB rat. Diabetes January 1999 48:43-49; doi:10.2337/diabetes.48.1.43

  9. Blankenhorn, E P

    • Non-major histocompatibility complex-linked diabetes susceptibility loci on chromosomes 4 and 13 in a backcross of the DP-BB/Wor rat to the WF rat. Diabetes January 1999 48:50-58; doi:10.2337/diabetes.48.1.50

  10. Bleackley, R C

    • Beta-cell destruction in NOD mice correlates with Fas (CD95) expression on beta-cells and proinflammatory cytokine expression in islets. Diabetes January 1999 48:21-28; doi:10.2337/diabetes.48.1.21

  11. Bloom, S R

    • Glucagon-like peptide 1 has a physiological role in the control of postprandial glucose in humans: studies with the antagonist exendin 9-39. Diabetes January 1999 48:86-93; doi:10.2337/diabetes.48.1.86

  12. Blumberg, M

    • Effects of recurrent hypoglycemia on brainstem function in diabetic BB rats: protective adaptation during acute hypoglycemia. Diabetes January 1999 48:141-145; doi:10.2337/diabetes.48.1.141

  13. Bogardus, C

    • Skeletal muscle uncoupling protein 3 expression is a determinant of energy expenditure in Pima Indians. Diabetes January 1999 48:146-149; doi:10.2337/diabetes.48.1.146

  14. Boutin, P

    • Mutation screening and association studies of the human uncoupling protein 3 gene in normoglycemic and diabetic morbidly obese patients. Diabetes January 1999 48:206-208

  15. Bouwens, L

    • Contribution of ductal cells to cytokine responses by human pancreatic islets. Diabetes January 1999 48:29-33; doi:10.2337/diabetes.48.1.29

  16. Brabant, G

    • No evidence for association between IDDMK(1,2)22, a novel isolated retrovirus, and IDDM. Diabetes January 1999 48:209-214; doi:10.2337/diabetes.48.1.209

  17. Brevi, M

    • Pituitary cotransplantation significantly improves the performance, insulin content, and vascularization of renal subcapsular islet grafts. Diabetes January 1999 48:59-65; doi:10.2337/diabetes.48.1.59

  18. Bruttomesso, D

    • Restoration of early rise in plasma insulin levels improves the glucose tolerance of type 2 diabetic patients. Diabetes January 1999 48:99-105; doi:10.2337/diabetes.48.1.99

  19. Burns, J

    • Dietary flavonols protect diabetic human lymphocytes against oxidative damage to DNA. Diabetes January 1999 48:176-181; doi:10.2337/diabetes.48.1.176

C

  1. Cambien, F

    • Polymorphism of the human beta3-adrenoceptor gene forms a well-conserved haplotype that is associated with moderate obesity and altered receptor function. Diabetes January 1999 48:203-205; doi:10.2337/diabetes.48.1.203

  2. Carallo, C

    • NIDDM is associated with lower wall shear stress of the common carotid artery. Diabetes January 1999 48:193-197; doi:10.2337/diabetes.48.1.193

  3. Carlsson, A

    • Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies. Diabetes January 1999 48:150-157; doi:10.2337/diabetes.48.1.150

  4. Cavallaro, U

    • Pituitary cotransplantation significantly improves the performance, insulin content, and vascularization of renal subcapsular islet grafts. Diabetes January 1999 48:59-65; doi:10.2337/diabetes.48.1.59

  5. Charron, M J

    • Downregulation of uncoupling protein 2 mRNA in white adipose tissue and uncoupling protein 3 mRNA in skeletal muscle during the early stages of leptin treatment. Diabetes January 1999 48:128-133; doi:10.2337/diabetes.48.1.128

  6. Chen, M C

    • Contribution of ductal cells to cytokine responses by human pancreatic islets. Diabetes January 1999 48:29-33; doi:10.2337/diabetes.48.1.29

  7. Chung, W

    • Mutation screening and association studies of the human uncoupling protein 3 gene in normoglycemic and diabetic morbidly obese patients. Diabetes January 1999 48:206-208

  8. Clement, K

    • Mutation screening and association studies of the human uncoupling protein 3 gene in normoglycemic and diabetic morbidly obese patients. Diabetes January 1999 48:206-208

  9. Cline, G W

    • Differential effects of safflower oil versus fish oil feeding on insulin-stimulated glycogen synthesis, glycolysis, and pyruvate dehydrogenase flux in skeletal muscle: a 13C nuclear magnetic resonance study. Diabetes January 1999 48:134-140; doi:10.2337/diabetes.48.1.134

  10. Cohen, P

    • Surgical removal of visceral fat reverses hepatic insulin resistance. Diabetes January 1999 48:94-98; doi:10.2337/diabetes.48.1.94

  11. Combatsiaris, T P

    • Downregulation of uncoupling protein 2 mRNA in white adipose tissue and uncoupling protein 3 mRNA in skeletal muscle during the early stages of leptin treatment. Diabetes January 1999 48:128-133; doi:10.2337/diabetes.48.1.128

  12. Crescenzo, A

    • NIDDM is associated with lower wall shear stress of the common carotid artery. Diabetes January 1999 48:193-197; doi:10.2337/diabetes.48.1.193

  13. Crozier, A

    • Dietary flavonols protect diabetic human lymphocytes against oxidative damage to DNA. Diabetes January 1999 48:176-181; doi:10.2337/diabetes.48.1.176

D

  1. Davalli, A M

    • Pituitary cotransplantation significantly improves the performance, insulin content, and vascularization of renal subcapsular islet grafts. Diabetes January 1999 48:59-65; doi:10.2337/diabetes.48.1.59

  2. De Franceschi, M S

    • NIDDM is associated with lower wall shear stress of the common carotid artery. Diabetes January 1999 48:193-197; doi:10.2337/diabetes.48.1.193

  3. Degerman, E

    • Hormone-sensitive lipase, the rate-limiting enzyme in triglyceride hydrolysis, is expressed and active in beta-cells. Diabetes January 1999 48:228-232; doi:10.2337/diabetes.48.1.228

  4. Del Prato, S

    • Restoration of early rise in plasma insulin levels improves the glucose tolerance of type 2 diabetic patients. Diabetes January 1999 48:99-105; doi:10.2337/diabetes.48.1.99

  5. Dietsch, G

    • Recombinant human platelet-activating factor acetylhydrolase reduces the frequency of diabetes in the diabetes-prone BB rat. Diabetes January 1999 48:43-49; doi:10.2337/diabetes.48.1.43

  6. Donner, H

    • IDDM patients neither show humoral reactivities against endogenous retroviral envelope protein nor do they differ in retroviral mRNA expression from healthy relatives or normal individuals. Diabetes January 1999 48:215-218; doi:10.2337/diabetes.48.1.215

  7. Dubois, S

    • Mutation screening and association studies of the human uncoupling protein 3 gene in normoglycemic and diabetic morbidly obese patients. Diabetes January 1999 48:206-208

  8. Dziura, J

    • Effects of recurrent hypoglycemia on brainstem function in diabetic BB rats: protective adaptation during acute hypoglycemia. Diabetes January 1999 48:141-145; doi:10.2337/diabetes.48.1.141

E

  1. Eckel, R H

    • Plasma triglyceride reduction in mice after direct injections of muscle-specific lipoprotein lipase DNA. Diabetes January 1999 48:223-227; doi:10.2337/diabetes.48.1.223

  2. Edwards, C M

    • Glucagon-like peptide 1 has a physiological role in the control of postprandial glucose in humans: studies with the antagonist exendin 9-39. Diabetes January 1999 48:86-93; doi:10.2337/diabetes.48.1.86

  3. Ehrnström, B O

    • Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies. Diabetes January 1999 48:150-157; doi:10.2337/diabetes.48.1.150

  4. Eizirik, D L

    • Contribution of ductal cells to cytokine responses by human pancreatic islets. Diabetes January 1999 48:29-33; doi:10.2337/diabetes.48.1.29

  5. Ekström, P

    • Heme oxygenase and carbon monoxide: regulatory roles in islet hormone release: a biochemical, immunohistochemical, and confocal microscopic study. Diabetes January 1999 48:66-76; doi:10.2337/diabetes.48.1.66

  6. Elliott, J F

    • Beta-cell destruction in NOD mice correlates with Fas (CD95) expression on beta-cells and proinflammatory cytokine expression in islets. Diabetes January 1999 48:21-28; doi:10.2337/diabetes.48.1.21

F

  1. Feingold, K R

    • Regulation of putative fatty acid transporters and Acyl-CoA synthetase in liver and adipose tissue in ob/ob mice. Diabetes January 1999 48:121-127; doi:10.2337/diabetes.48.1.121

  2. Forsblom, C

    • Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies. Diabetes January 1999 48:150-157; doi:10.2337/diabetes.48.1.150

  3. Forsén, B

    • Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies. Diabetes January 1999 48:150-157; doi:10.2337/diabetes.48.1.150

  4. Freschi, M

    • Pituitary cotransplantation significantly improves the performance, insulin content, and vascularization of renal subcapsular islet grafts. Diabetes January 1999 48:59-65; doi:10.2337/diabetes.48.1.59

  5. Froguel, P

    • Mutation screening and association studies of the human uncoupling protein 3 gene in normoglycemic and diabetic morbidly obese patients. Diabetes January 1999 48:206-208

  6. Fukushima, Y

    • Enhanced insulin-stimulated activation of phosphatidylinositol 3-kinase in the liver of high-fat-fed rats. Diabetes January 1999 48:158-169; doi:10.2337/diabetes.48.1.158

  7. Fuller, J

    • Regulation of putative fatty acid transporters and Acyl-CoA synthetase in liver and adipose tissue in ob/ob mice. Diabetes January 1999 48:121-127; doi:10.2337/diabetes.48.1.121

  8. Funaki, M

    • Enhanced insulin-stimulated activation of phosphatidylinositol 3-kinase in the liver of high-fat-fed rats. Diabetes January 1999 48:158-169; doi:10.2337/diabetes.48.1.158

G

  1. Ghatei, M A

    • Glucagon-like peptide 1 has a physiological role in the control of postprandial glucose in humans: studies with the antagonist exendin 9-39. Diabetes January 1999 48:86-93; doi:10.2337/diabetes.48.1.86

  2. Gnasso, A

    • NIDDM is associated with lower wall shear stress of the common carotid artery. Diabetes January 1999 48:193-197; doi:10.2337/diabetes.48.1.193

  3. Graham, J

    • Recombinant human platelet-activating factor acetylhydrolase reduces the frequency of diabetes in the diabetes-prone BB rat. Diabetes January 1999 48:43-49; doi:10.2337/diabetes.48.1.43

  4. Greenbaum, C J

    • Relationship of beta-cell function and autoantibodies to progression and nonprogression of subclinical type 1 diabetes: follow-up of the Seattle Family Study. Diabetes January 1999 48:170-175; doi:10.2337/diabetes.48.1.170

  5. Greiner, D L

    • Non-major histocompatibility complex-linked diabetes susceptibility loci on chromosomes 4 and 13 in a backcross of the DP-BB/Wor rat to the WF rat. Diabetes January 1999 48:50-58; doi:10.2337/diabetes.48.1.50

  6. Groop, L C

    • Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies. Diabetes January 1999 48:150-157; doi:10.2337/diabetes.48.1.150

  7. Gross, K

    • Under control of the Ren-1c promoter, locally produced transforming growth factor-beta1 induces accumulation of glomerular extracellular matrix in transgenic mice. Diabetes January 1999 48:182-192; doi:10.2337/diabetes.48.1.182

  8. Grunfeld, C

    • Regulation of putative fatty acid transporters and Acyl-CoA synthetase in liver and adipose tissue in ob/ob mice. Diabetes January 1999 48:121-127; doi:10.2337/diabetes.48.1.121

  9. Guy-Grand, B

    • Mutation screening and association studies of the human uncoupling protein 3 gene in normoglycemic and diabetic morbidly obese patients. Diabetes January 1999 48:206-208

H

  1. Henningsson, R

    • Heme oxygenase and carbon monoxide: regulatory roles in islet hormone release: a biochemical, immunohistochemical, and confocal microscopic study. Diabetes January 1999 48:66-76; doi:10.2337/diabetes.48.1.66

  2. Heringlake, S

    • No evidence for association between IDDMK(1,2)22, a novel isolated retrovirus, and IDDM. Diabetes January 1999 48:209-214; doi:10.2337/diabetes.48.1.209

  3. Herrmann, S M

    • Polymorphism of the human beta3-adrenoceptor gene forms a well-conserved haplotype that is associated with moderate obesity and altered receptor function. Diabetes January 1999 48:203-205; doi:10.2337/diabetes.48.1.203

  4. Herwig, J

    • IDDM patients neither show humoral reactivities against endogenous retroviral envelope protein nor do they differ in retroviral mRNA expression from healthy relatives or normal individuals. Diabetes January 1999 48:215-218; doi:10.2337/diabetes.48.1.215

  5. Hjorth, P

    • Under control of the Ren-1c promoter, locally produced transforming growth factor-beta1 induces accumulation of glomerular extracellular matrix in transgenic mice. Diabetes January 1999 48:182-192; doi:10.2337/diabetes.48.1.182

  6. Hoffstedt, J

    • Polymorphism of the human beta3-adrenoceptor gene forms a well-conserved haplotype that is associated with moderate obesity and altered receptor function. Diabetes January 1999 48:203-205; doi:10.2337/diabetes.48.1.203

  7. Holm, C

    • Hormone-sensitive lipase, the rate-limiting enzyme in triglyceride hydrolysis, is expressed and active in beta-cells. Diabetes January 1999 48:228-232; doi:10.2337/diabetes.48.1.228

  8. Holmäng, A

    • Induction of insulin resistance by glucosamine reduces blood flow but not interstitial levels of either glucose or insulin. Diabetes January 1999 48:106-111; doi:10.2337/diabetes.48.1.106

  9. Holst, L S

    • Hormone-sensitive lipase, the rate-limiting enzyme in triglyceride hydrolysis, is expressed and active in beta-cells. Diabetes January 1999 48:228-232; doi:10.2337/diabetes.48.1.228

  10. Honjyo, H

    • Trp64Arg mutation of beta3-adrenoceptor gene deteriorates lipolysis induced by beta3-adrenoceptor agonist in human omental adipocytes. Diabetes January 1999 48:117-120; doi:10.2337/diabetes.48.1.117

  11. Howell, S K

    • Metformin reduces systemic methylglyoxal levels in type 2 diabetes. Diabetes January 1999 48:198-202; doi:10.2337/diabetes.48.1.198

  12. Hunsmann, G

    • No evidence for association between IDDMK(1,2)22, a novel isolated retrovirus, and IDDM. Diabetes January 1999 48:209-214; doi:10.2337/diabetes.48.1.209

I

  1. Inukai, K

    • Enhanced insulin-stimulated activation of phosphatidylinositol 3-kinase in the liver of high-fat-fed rats. Diabetes January 1999 48:158-169; doi:10.2337/diabetes.48.1.158

  2. Irace, C

    • NIDDM is associated with lower wall shear stress of the common carotid artery. Diabetes January 1999 48:193-197; doi:10.2337/diabetes.48.1.193

  3. Isomaa, B

    • Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies. Diabetes January 1999 48:150-157; doi:10.2337/diabetes.48.1.150

J

  1. Jacob, R J

    • Effects of recurrent hypoglycemia on brainstem function in diabetic BB rats: protective adaptation during acute hypoglycemia. Diabetes January 1999 48:141-145; doi:10.2337/diabetes.48.1.141

  2. Jaeckel, E

    • No evidence for association between IDDMK(1,2)22, a novel isolated retrovirus, and IDDM. Diabetes January 1999 48:209-214; doi:10.2337/diabetes.48.1.209

  3. Jensen, M D

    • Insulin regulation of regional free fatty acid metabolism. Diabetes January 1999 48:10-14; doi:10.2337/diabetes.48.1.10

  4. Jiang, J

    • Recombinant human platelet-activating factor acetylhydrolase reduces the frequency of diabetes in the diabetes-prone BB rat. Diabetes January 1999 48:43-49; doi:10.2337/diabetes.48.1.43

  5. Jucker, B M

    • Differential effects of safflower oil versus fish oil feeding on insulin-stimulated glycogen synthesis, glycolysis, and pyruvate dehydrogenase flux in skeletal muscle: a 13C nuclear magnetic resonance study. Diabetes January 1999 48:134-140; doi:10.2337/diabetes.48.1.134

  6. Jun, H S

    • Absolute requirement of macrophages for the development and activation of beta-cell cytotoxic CD8+ T-cells in T-cell receptor transgenic NOD mice. Diabetes January 1999 48:34-42; doi:10.2337/diabetes.48.1.34

K

  1. Kahn, S E

    • Relationship of beta-cell function and autoantibodies to progression and nonprogression of subclinical type 1 diabetes: follow-up of the Seattle Family Study. Diabetes January 1999 48:170-175; doi:10.2337/diabetes.48.1.170

  2. Kanda, A

    • Enhanced insulin-stimulated activation of phosphatidylinositol 3-kinase in the liver of high-fat-fed rats. Diabetes January 1999 48:158-169; doi:10.2337/diabetes.48.1.158

  3. Kelly, I

    • Dietary flavonols protect diabetic human lymphocytes against oxidative damage to DNA. Diabetes January 1999 48:176-181; doi:10.2337/diabetes.48.1.176

  4. Kikuchi, M

    • Enhanced insulin-stimulated activation of phosphatidylinositol 3-kinase in the liver of high-fat-fed rats. Diabetes January 1999 48:158-169; doi:10.2337/diabetes.48.1.158

  5. Kogure, A

    • Trp64Arg mutation of beta3-adrenoceptor gene deteriorates lipolysis induced by beta3-adrenoceptor agonist in human omental adipocytes. Diabetes January 1999 48:117-120; doi:10.2337/diabetes.48.1.117

  6. Kondo, M

    • Trp64Arg mutation of beta3-adrenoceptor gene deteriorates lipolysis induced by beta3-adrenoceptor agonist in human omental adipocytes. Diabetes January 1999 48:117-120; doi:10.2337/diabetes.48.1.117

  7. Kumar, U

    • Subtype-selective expression of the five somatostatin receptors (hSSTR1-5) in human pancreatic islet cells: a quantitative double-label immunohistochemical analysis. Diabetes January 1999 48:77-85; doi:10.2337/diabetes.48.1.77

  8. Kurth, R

    • IDDM patients neither show humoral reactivities against endogenous retroviral envelope protein nor do they differ in retroviral mRNA expression from healthy relatives or normal individuals. Diabetes January 1999 48:215-218; doi:10.2337/diabetes.48.1.215

L

  1. Lahti, K

    • Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies. Diabetes January 1999 48:150-157; doi:10.2337/diabetes.48.1.150

  2. Lal, S

    • Metformin reduces systemic methylglyoxal levels in type 2 diabetes. Diabetes January 1999 48:198-202; doi:10.2337/diabetes.48.1.198

  3. Larsson, B M

    • Induction of insulin resistance by glucosamine reduces blood flow but not interstitial levels of either glucose or insulin. Diabetes January 1999 48:106-111; doi:10.2337/diabetes.48.1.106

  4. Lean, M E

    • Dietary flavonols protect diabetic human lymphocytes against oxidative damage to DNA. Diabetes January 1999 48:176-181; doi:10.2337/diabetes.48.1.176

  5. Ledet, T

    • Under control of the Ren-1c promoter, locally produced transforming growth factor-beta1 induces accumulation of glomerular extracellular matrix in transgenic mice. Diabetes January 1999 48:182-192; doi:10.2337/diabetes.48.1.182

  6. Lee, E S

    • Recombinant human platelet-activating factor acetylhydrolase reduces the frequency of diabetes in the diabetes-prone BB rat. Diabetes January 1999 48:43-49; doi:10.2337/diabetes.48.1.43

  7. Leibel, R

    • Mutation screening and association studies of the human uncoupling protein 3 gene in normoglycemic and diabetic morbidly obese patients. Diabetes January 1999 48:206-208

  8. Leif, J

    • Non-major histocompatibility complex-linked diabetes susceptibility loci on chromosomes 4 and 13 in a backcross of the DP-BB/Wor rat to the WF rat. Diabetes January 1999 48:50-58; doi:10.2337/diabetes.48.1.50

  9. Lepretre, F

    • Mutation screening and association studies of the human uncoupling protein 3 gene in normoglycemic and diabetic morbidly obese patients. Diabetes January 1999 48:206-208

  10. Lernmark, A

    • Recombinant human platelet-activating factor acetylhydrolase reduces the frequency of diabetes in the diabetes-prone BB rat. Diabetes January 1999 48:43-49; doi:10.2337/diabetes.48.1.43

  11. Li, H

    • Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies. Diabetes January 1999 48:150-157; doi:10.2337/diabetes.48.1.150

  12. Lim, H W

    • Absolute requirement of macrophages for the development and activation of beta-cell cytotoxic CD8+ T-cells in T-cell receptor transgenic NOD mice. Diabetes January 1999 48:34-42; doi:10.2337/diabetes.48.1.34

  13. Liu, B Q

    • Surgical removal of visceral fat reverses hepatic insulin resistance. Diabetes January 1999 48:94-98; doi:10.2337/diabetes.48.1.94

  14. Lundquist, I

    • Heme oxygenase and carbon monoxide: regulatory roles in islet hormone release: a biochemical, immunohistochemical, and confocal microscopic study. Diabetes January 1999 48:66-76; doi:10.2337/diabetes.48.1.66

  15. Lönnqvist, F

    • Polymorphism of the human beta3-adrenoceptor gene forms a well-conserved haplotype that is associated with moderate obesity and altered receptor function. Diabetes January 1999 48:203-205; doi:10.2337/diabetes.48.1.203

  16. Lönroth, P

    • Induction of insulin resistance by glucosamine reduces blood flow but not interstitial levels of either glucose or insulin. Diabetes January 1999 48:106-111; doi:10.2337/diabetes.48.1.106

M

  1. Mahmoudi, M

    • Glucagon-like peptide 1 has a physiological role in the control of postprandial glucose in humans: studies with the antagonist exendin 9-39. Diabetes January 1999 48:86-93; doi:10.2337/diabetes.48.1.86

  2. Manns, M P

    • No evidence for association between IDDMK(1,2)22, a novel isolated retrovirus, and IDDM. Diabetes January 1999 48:209-214; doi:10.2337/diabetes.48.1.209

  3. Marescotti, M C

    • Restoration of early rise in plasma insulin levels improves the glucose tolerance of type 2 diabetic patients. Diabetes January 1999 48:99-105; doi:10.2337/diabetes.48.1.99

  4. Mari, A

    • Restoration of early rise in plasma insulin levels improves the glucose tolerance of type 2 diabetic patients. Diabetes January 1999 48:99-105; doi:10.2337/diabetes.48.1.99

  5. Marron, M P

    • The IDDMK(1,2)22 retrovirus is not detectable in either mRNA or genomic DNA from patients with type 1 diabetes. Diabetes January 1999 48:219-222; doi:10.2337/diabetes.48.1.219

  6. Martin, A M

    • Non-major histocompatibility complex-linked diabetes susceptibility loci on chromosomes 4 and 13 in a backcross of the DP-BB/Wor rat to the WF rat. Diabetes January 1999 48:50-58; doi:10.2337/diabetes.48.1.50

  7. Mattioli, P L

    • NIDDM is associated with lower wall shear stress of the common carotid artery. Diabetes January 1999 48:193-197; doi:10.2337/diabetes.48.1.193

  8. Maxson, M N

    • Non-major histocompatibility complex-linked diabetes susceptibility loci on chromosomes 4 and 13 in a backcross of the DP-BB/Wor rat to the WF rat. Diabetes January 1999 48:50-58; doi:10.2337/diabetes.48.1.50

  9. Meek, S E

    • Insulin regulation of regional free fatty acid metabolism. Diabetes January 1999 48:10-14; doi:10.2337/diabetes.48.1.10

  10. Memon, R A

    • Regulation of putative fatty acid transporters and Acyl-CoA synthetase in liver and adipose tissue in ob/ob mice. Diabetes January 1999 48:121-127; doi:10.2337/diabetes.48.1.121

  11. Metrakos, P

    • Subtype-selective expression of the five somatostatin receptors (hSSTR1-5) in human pancreatic islet cells: a quantitative double-label immunohistochemical analysis. Diabetes January 1999 48:77-85; doi:10.2337/diabetes.48.1.77

  12. Miettinen, A

    • Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies. Diabetes January 1999 48:150-157; doi:10.2337/diabetes.48.1.150

  13. Mordes, J P

    • Non-major histocompatibility complex-linked diabetes susceptibility loci on chromosomes 4 and 13 in a backcross of the DP-BB/Wor rat to the WF rat. Diabetes January 1999 48:50-58; doi:10.2337/diabetes.48.1.50

  14. Morgen, J P

    • Effects of recurrent hypoglycemia on brainstem function in diabetic BB rats: protective adaptation during acute hypoglycemia. Diabetes January 1999 48:141-145; doi:10.2337/diabetes.48.1.141

  15. Moser, A H

    • Regulation of putative fatty acid transporters and Acyl-CoA synthetase in liver and adipose tissue in ob/ob mice. Diabetes January 1999 48:121-127; doi:10.2337/diabetes.48.1.121

  16. Motti, C

    • NIDDM is associated with lower wall shear stress of the common carotid artery. Diabetes January 1999 48:193-197; doi:10.2337/diabetes.48.1.193

  17. Muir, A

    • The IDDMK(1,2)22 retrovirus is not detectable in either mRNA or genomic DNA from patients with type 1 diabetes. Diabetes January 1999 48:219-222; doi:10.2337/diabetes.48.1.219

  18. Mulder, H

    • Hormone-sensitive lipase, the rate-limiting enzyme in triglyceride hydrolysis, is expressed and active in beta-cells. Diabetes January 1999 48:228-232; doi:10.2337/diabetes.48.1.228

N

  1. Nair, K S

    • Insulin regulation of regional free fatty acid metabolism. Diabetes January 1999 48:10-14; doi:10.2337/diabetes.48.1.10

  2. Nawano, M

    • Enhanced insulin-stimulated activation of phosphatidylinositol 3-kinase in the liver of high-fat-fed rats. Diabetes January 1999 48:158-169; doi:10.2337/diabetes.48.1.158

  3. Neumann, J

    • IDDM patients neither show humoral reactivities against endogenous retroviral envelope protein nor do they differ in retroviral mRNA expression from healthy relatives or normal individuals. Diabetes January 1999 48:215-218; doi:10.2337/diabetes.48.1.215

  4. Nielsen, A H

    • Under control of the Ren-1c promoter, locally produced transforming growth factor-beta1 induces accumulation of glomerular extracellular matrix in transgenic mice. Diabetes January 1999 48:182-192; doi:10.2337/diabetes.48.1.182

  5. Nielsen, C B

    • Under control of the Ren-1c promoter, locally produced transforming growth factor-beta1 induces accumulation of glomerular extracellular matrix in transgenic mice. Diabetes January 1999 48:182-192; doi:10.2337/diabetes.48.1.182

  6. Niklasson, M

    • Induction of insulin resistance by glucosamine reduces blood flow but not interstitial levels of either glucose or insulin. Diabetes January 1999 48:106-111; doi:10.2337/diabetes.48.1.106

  7. Nilsson, A

    • Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies. Diabetes January 1999 48:150-157; doi:10.2337/diabetes.48.1.150

  8. Nilsson, C

    • Induction of insulin resistance by glucosamine reduces blood flow but not interstitial levels of either glucose or insulin. Diabetes January 1999 48:106-111; doi:10.2337/diabetes.48.1.106

  9. Nissén, M

    • Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies. Diabetes January 1999 48:150-157; doi:10.2337/diabetes.48.1.150

  10. Noroozi, M

    • Dietary flavonols protect diabetic human lymphocytes against oxidative damage to DNA. Diabetes January 1999 48:176-181; doi:10.2337/diabetes.48.1.176

O

  1. O'Connor, J

    • Relationships between maternal risk of insulin resistance and the child's muscle membrane fatty acid composition. Diabetes January 1999 48:112-116; doi:10.2337/diabetes.48.1.112

  2. Ogihara, T

    • Enhanced insulin-stimulated activation of phosphatidylinositol 3-kinase in the liver of high-fat-fed rats. Diabetes January 1999 48:158-169; doi:10.2337/diabetes.48.1.158

  3. Oka, Y

    • Enhanced insulin-stimulated activation of phosphatidylinositol 3-kinase in the liver of high-fat-fed rats. Diabetes January 1999 48:158-169; doi:10.2337/diabetes.48.1.158

  4. Onishi, Y

    • Enhanced insulin-stimulated activation of phosphatidylinositol 3-kinase in the liver of high-fat-fed rats. Diabetes January 1999 48:158-169; doi:10.2337/diabetes.48.1.158

  5. Otabe, S

    • Mutation screening and association studies of the human uncoupling protein 3 gene in normoglycemic and diabetic morbidly obese patients. Diabetes January 1999 48:206-208

P

  1. Palmer, J P

    • Relationship of beta-cell function and autoantibodies to progression and nonprogression of subclinical type 1 diabetes: follow-up of the Seattle Family Study. Diabetes January 1999 48:170-175; doi:10.2337/diabetes.48.1.170

  2. Pan, D A

    • Relationships between maternal risk of insulin resistance and the child's muscle membrane fatty acid composition. Diabetes January 1999 48:112-116; doi:10.2337/diabetes.48.1.112

  3. Parlow, A F

    • Pituitary cotransplantation significantly improves the performance, insulin content, and vascularization of renal subcapsular islet grafts. Diabetes January 1999 48:59-65; doi:10.2337/diabetes.48.1.59

  4. Patel, A

    • Subtype-selective expression of the five somatostatin receptors (hSSTR1-5) in human pancreatic islet cells: a quantitative double-label immunohistochemical analysis. Diabetes January 1999 48:77-85; doi:10.2337/diabetes.48.1.77

  5. Patel, S C

    • Subtype-selective expression of the five somatostatin receptors (hSSTR1-5) in human pancreatic islet cells: a quantitative double-label immunohistochemical analysis. Diabetes January 1999 48:77-85; doi:10.2337/diabetes.48.1.77

  6. Patel, Y C

    • Subtype-selective expression of the five somatostatin receptors (hSSTR1-5) in human pancreatic islet cells: a quantitative double-label immunohistochemical analysis. Diabetes January 1999 48:77-85; doi:10.2337/diabetes.48.1.77

  7. Pavlovic, D

    • Contribution of ductal cells to cytokine responses by human pancreatic islets. Diabetes January 1999 48:29-33; doi:10.2337/diabetes.48.1.29

  8. Pelloux, V

    • Mutation screening and association studies of the human uncoupling protein 3 gene in normoglycemic and diabetic morbidly obese patients. Diabetes January 1999 48:206-208

  9. Peterman, G

    • Recombinant human platelet-activating factor acetylhydrolase reduces the frequency of diabetes in the diabetes-prone BB rat. Diabetes January 1999 48:43-49; doi:10.2337/diabetes.48.1.43

  10. Pianta, A

    • Restoration of early rise in plasma insulin levels improves the glucose tolerance of type 2 diabetic patients. Diabetes January 1999 48:99-105; doi:10.2337/diabetes.48.1.99

  11. Pipeleers, D

    • Contribution of ductal cells to cytokine responses by human pancreatic islets. Diabetes January 1999 48:29-33; doi:10.2337/diabetes.48.1.29

  12. Poirier, O

    • Polymorphism of the human beta3-adrenoceptor gene forms a well-conserved haplotype that is associated with moderate obesity and altered receptor function. Diabetes January 1999 48:203-205; doi:10.2337/diabetes.48.1.203

  13. Pontiroli, A E

    • Pituitary cotransplantation significantly improves the performance, insulin content, and vascularization of renal subcapsular islet grafts. Diabetes January 1999 48:59-65; doi:10.2337/diabetes.48.1.59

  14. Pratley, R E

    • Skeletal muscle uncoupling protein 3 expression is a determinant of energy expenditure in Pima Indians. Diabetes January 1999 48:146-149; doi:10.2337/diabetes.48.1.146

R

  1. Rabinovitch, A

    • Beta-cell destruction in NOD mice correlates with Fas (CD95) expression on beta-cells and proinflammatory cytokine expression in islets. Diabetes January 1999 48:21-28; doi:10.2337/diabetes.48.1.21

  2. Rajotte, R V

    • Beta-cell destruction in NOD mice correlates with Fas (CD95) expression on beta-cells and proinflammatory cytokine expression in islets. Diabetes January 1999 48:21-28; doi:10.2337/diabetes.48.1.21

  3. Rasmussen, L M

    • Under control of the Ren-1c promoter, locally produced transforming growth factor-beta1 induces accumulation of glomerular extracellular matrix in transgenic mice. Diabetes January 1999 48:182-192; doi:10.2337/diabetes.48.1.182

  4. Ravussin, E

    • Skeletal muscle uncoupling protein 3 expression is a determinant of energy expenditure in Pima Indians. Diabetes January 1999 48:146-149; doi:10.2337/diabetes.48.1.146

  5. Rorsman, P

    • Hormone-sensitive lipase, the rate-limiting enzyme in triglyceride hydrolysis, is expressed and active in beta-cells. Diabetes January 1999 48:228-232; doi:10.2337/diabetes.48.1.228

  6. Rossetti, L

    • Surgical removal of visceral fat reverses hepatic insulin resistance. Diabetes January 1999 48:94-98; doi:10.2337/diabetes.48.1.94

  7. Ruan, Q G

    • The IDDMK(1,2)22 retrovirus is not detectable in either mRNA or genomic DNA from patients with type 1 diabetes. Diabetes January 1999 48:219-222; doi:10.2337/diabetes.48.1.219

S

  1. Sakane, N

    • Trp64Arg mutation of beta3-adrenoceptor gene deteriorates lipolysis induced by beta3-adrenoceptor agonist in human omental adipocytes. Diabetes January 1999 48:117-120; doi:10.2337/diabetes.48.1.117

  2. Sakoda, H

    • Enhanced insulin-stimulated activation of phosphatidylinositol 3-kinase in the liver of high-fat-fed rats. Diabetes January 1999 48:158-169; doi:10.2337/diabetes.48.1.158

  3. Saloranta, C

    • Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies. Diabetes January 1999 48:150-157; doi:10.2337/diabetes.48.1.150

  4. Santamaria, P

    • Absolute requirement of macrophages for the development and activation of beta-cell cytotoxic CD8+ T-cells in T-cell receptor transgenic NOD mice. Diabetes January 1999 48:34-42; doi:10.2337/diabetes.48.1.34

  5. Sanvito, F

    • Pituitary cotransplantation significantly improves the performance, insulin content, and vascularization of renal subcapsular islet grafts. Diabetes January 1999 48:59-65; doi:10.2337/diabetes.48.1.59

  6. Sarvetnick, N

    • Under control of the Ren-1c promoter, locally produced transforming growth factor-beta1 induces accumulation of glomerular extracellular matrix in transgenic mice. Diabetes January 1999 48:182-192; doi:10.2337/diabetes.48.1.182

  7. Sasi, R

    • Subtype-selective expression of the five somatostatin receptors (hSSTR1-5) in human pancreatic islet cells: a quantitative double-label immunohistochemical analysis. Diabetes January 1999 48:77-85; doi:10.2337/diabetes.48.1.77

  8. Sattar, N

    • Dietary flavonols protect diabetic human lymphocytes against oxidative damage to DNA. Diabetes January 1999 48:176-181; doi:10.2337/diabetes.48.1.176

  9. Scaglia, L

    • Pituitary cotransplantation significantly improves the performance, insulin content, and vascularization of renal subcapsular islet grafts. Diabetes January 1999 48:59-65; doi:10.2337/diabetes.48.1.59

  10. Schimpf, B

    • Recombinant human platelet-activating factor acetylhydrolase reduces the frequency of diabetes in the diabetes-prone BB rat. Diabetes January 1999 48:43-49; doi:10.2337/diabetes.48.1.43

  11. Schlaepfer, I R

    • Plasma triglyceride reduction in mice after direct injections of muscle-specific lipoprotein lipase DNA. Diabetes January 1999 48:223-227; doi:10.2337/diabetes.48.1.223

  12. Schrauwen, P

    • Skeletal muscle uncoupling protein 3 expression is a determinant of energy expenditure in Pima Indians. Diabetes January 1999 48:146-149; doi:10.2337/diabetes.48.1.146

  13. Sears, K L

    • Relationship of beta-cell function and autoantibodies to progression and nonprogression of subclinical type 1 diabetes: follow-up of the Seattle Family Study. Diabetes January 1999 48:170-175; doi:10.2337/diabetes.48.1.170

  14. She, J X

    • The IDDMK(1,2)22 retrovirus is not detectable in either mRNA or genomic DNA from patients with type 1 diabetes. Diabetes January 1999 48:219-222; doi:10.2337/diabetes.48.1.219

  15. She, L

    • Surgical removal of visceral fat reverses hepatic insulin resistance. Diabetes January 1999 48:94-98; doi:10.2337/diabetes.48.1.94

  16. Sherwin, R S

    • Effects of recurrent hypoglycemia on brainstem function in diabetic BB rats: protective adaptation during acute hypoglycemia. Diabetes January 1999 48:141-145; doi:10.2337/diabetes.48.1.141

  17. Shulman, G I

    • Differential effects of safflower oil versus fish oil feeding on insulin-stimulated glycogen synthesis, glycolysis, and pyruvate dehydrogenase flux in skeletal muscle: a 13C nuclear magnetic resonance study. Diabetes January 1999 48:134-140; doi:10.2337/diabetes.48.1.134

  18. Simonson, W T

    • Recombinant human platelet-activating factor acetylhydrolase reduces the frequency of diabetes in the diabetes-prone BB rat. Diabetes January 1999 48:43-49; doi:10.2337/diabetes.48.1.43

  19. Smith, P J

    • Regulation of putative fatty acid transporters and Acyl-CoA synthetase in liver and adipose tissue in ob/ob mice. Diabetes January 1999 48:121-127; doi:10.2337/diabetes.48.1.121

  20. Snickars, B

    • Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies. Diabetes January 1999 48:150-157; doi:10.2337/diabetes.48.1.150

  21. Sorensen, O

    • Beta-cell destruction in NOD mice correlates with Fas (CD95) expression on beta-cells and proinflammatory cytokine expression in islets. Diabetes January 1999 48:21-28; doi:10.2337/diabetes.48.1.21

  22. Storlien, L H

    • Relationships between maternal risk of insulin resistance and the child's muscle membrane fatty acid composition. Diabetes January 1999 48:112-116; doi:10.2337/diabetes.48.1.112

  23. Suarez-Pinzon, W

    • Beta-cell destruction in NOD mice correlates with Fas (CD95) expression on beta-cells and proinflammatory cytokine expression in islets. Diabetes January 1999 48:21-28; doi:10.2337/diabetes.48.1.21

  24. Sund, G C

    • Recombinant human platelet-activating factor acetylhydrolase reduces the frequency of diabetes in the diabetes-prone BB rat. Diabetes January 1999 48:43-49; doi:10.2337/diabetes.48.1.43

  25. Sundler, F

    • Hormone-sensitive lipase, the rate-limiting enzyme in triglyceride hydrolysis, is expressed and active in beta-cells. Diabetes January 1999 48:228-232; doi:10.2337/diabetes.48.1.228

  26. Suresh, S

    • Subtype-selective expression of the five somatostatin receptors (hSSTR1-5) in human pancreatic islet cells: a quantitative double-label immunohistochemical analysis. Diabetes January 1999 48:77-85; doi:10.2337/diabetes.48.1.77

  27. Svensson, H

    • Hormone-sensitive lipase, the rate-limiting enzyme in triglyceride hydrolysis, is expressed and active in beta-cells. Diabetes January 1999 48:228-232; doi:10.2337/diabetes.48.1.228

  28. Szwergold, B S

    • Metformin reduces systemic methylglyoxal levels in type 2 diabetes. Diabetes January 1999 48:198-202; doi:10.2337/diabetes.48.1.198

T

  1. Talwar, D

    • Dietary flavonols protect diabetic human lymphocytes against oxidative damage to DNA. Diabetes January 1999 48:176-181; doi:10.2337/diabetes.48.1.176

  2. Taskinen, M R

    • Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies. Diabetes January 1999 48:150-157; doi:10.2337/diabetes.48.1.150

  3. Thangaraju, M

    • Subtype-selective expression of the five somatostatin receptors (hSSTR1-5) in human pancreatic islet cells: a quantitative double-label immunohistochemical analysis. Diabetes January 1999 48:77-85; doi:10.2337/diabetes.48.1.77

  4. Thorpe, S R

    • Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes January 1999 48:1-9; doi:10.2337/diabetes.48.1.1

  5. Thörne, A

    • Polymorphism of the human beta3-adrenoceptor gene forms a well-conserved haplotype that is associated with moderate obesity and altered receptor function. Diabetes January 1999 48:203-205; doi:10.2337/diabetes.48.1.203

  6. Tiengo, A

    • Restoration of early rise in plasma insulin levels improves the glucose tolerance of type 2 diabetic patients. Diabetes January 1999 48:99-105; doi:10.2337/diabetes.48.1.99

  7. Todd, J F

    • Glucagon-like peptide 1 has a physiological role in the control of postprandial glucose in humans: studies with the antagonist exendin 9-39. Diabetes January 1999 48:86-93; doi:10.2337/diabetes.48.1.86

  8. Touchette, A D

    • Metformin reduces systemic methylglyoxal levels in type 2 diabetes. Diabetes January 1999 48:198-202; doi:10.2337/diabetes.48.1.198

  9. Tuomi, T

    • Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies. Diabetes January 1999 48:150-157; doi:10.2337/diabetes.48.1.150

  10. Tönjes, R R

    • IDDM patients neither show humoral reactivities against endogenous retroviral envelope protein nor do they differ in retroviral mRNA expression from healthy relatives or normal individuals. Diabetes January 1999 48:215-218; doi:10.2337/diabetes.48.1.215

U

  1. Umekawa, T

    • Trp64Arg mutation of beta3-adrenoceptor gene deteriorates lipolysis induced by beta3-adrenoceptor agonist in human omental adipocytes. Diabetes January 1999 48:117-120; doi:10.2337/diabetes.48.1.117

  2. Usadel, K H

    • IDDM patients neither show humoral reactivities against endogenous retroviral envelope protein nor do they differ in retroviral mRNA expression from healthy relatives or normal individuals. Diabetes January 1999 48:215-218; doi:10.2337/diabetes.48.1.215

V

  1. Valerio, A

    • Restoration of early rise in plasma insulin levels improves the glucose tolerance of type 2 diabetic patients. Diabetes January 1999 48:99-105; doi:10.2337/diabetes.48.1.99

  2. Vasseur, F

    • Mutation screening and association studies of the human uncoupling protein 3 gene in normoglycemic and diabetic morbidly obese patients. Diabetes January 1999 48:206-208

  3. Vuguin, P

    • Surgical removal of visceral fat reverses hepatic insulin resistance. Diabetes January 1999 48:94-98; doi:10.2337/diabetes.48.1.94

W

  1. Wang, J

    • Surgical removal of visceral fat reverses hepatic insulin resistance. Diabetes January 1999 48:94-98; doi:10.2337/diabetes.48.1.94

  2. Wang, R M

    • Glucagon-like peptide 1 has a physiological role in the control of postprandial glucose in humans: studies with the antagonist exendin 9-39. Diabetes January 1999 48:86-93; doi:10.2337/diabetes.48.1.86

  3. Wang, Z

    • Glucagon-like peptide 1 has a physiological role in the control of postprandial glucose in humans: studies with the antagonist exendin 9-39. Diabetes January 1999 48:86-93; doi:10.2337/diabetes.48.1.86

  4. Wogensen, L

    • Under control of the Ren-1c promoter, locally produced transforming growth factor-beta1 induces accumulation of glomerular extracellular matrix in transgenic mice. Diabetes January 1999 48:182-192; doi:10.2337/diabetes.48.1.182

X

  1. Xia, J

    • Skeletal muscle uncoupling protein 3 expression is a determinant of energy expenditure in Pima Indians. Diabetes January 1999 48:146-149; doi:10.2337/diabetes.48.1.146

Y

  1. Yazaki, Y

    • Enhanced insulin-stimulated activation of phosphatidylinositol 3-kinase in the liver of high-fat-fed rats. Diabetes January 1999 48:158-169; doi:10.2337/diabetes.48.1.158

  2. Yoon, J W

    • Absolute requirement of macrophages for the development and activation of beta-cell cytotoxic CD8+ T-cells in T-cell receptor transgenic NOD mice. Diabetes January 1999 48:34-42; doi:10.2337/diabetes.48.1.34

  3. Yoshida, T

    • Trp64Arg mutation of beta3-adrenoceptor gene deteriorates lipolysis induced by beta3-adrenoceptor agonist in human omental adipocytes. Diabetes January 1999 48:117-120; doi:10.2337/diabetes.48.1.117

Z

  1. Zhang, M L

    • Absolute requirement of macrophages for the development and activation of beta-cell cytotoxic CD8+ T-cells in T-cell receptor transgenic NOD mice. Diabetes January 1999 48:34-42; doi:10.2337/diabetes.48.1.34

  2. Zhao, M

    • Non-major histocompatibility complex-linked diabetes susceptibility loci on chromosomes 4 and 13 in a backcross of the DP-BB/Wor rat to the WF rat. Diabetes January 1999 48:50-58; doi:10.2337/diabetes.48.1.50

Current Issue

  1. March 2010, 59 (3)
    Current Issue
  1. Alert me to new issues of Diabetes